Comparing Ocrelizumab vs Tysabri
Ocrelizumab | Tysabri |
|
---|
Ocrelizumab | Tysabri (natalizumab) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Multiple Sclerosis. ocrelizumab may also be used for purposes not listed in this medication guide. |
Prescription only
Tysabri may be used to treat adults with multiple sclerosis or Crohn's disease and is given once every four weeks through an infusion center registered with the Touch Prescribing Program. A headache... View more |
||||||||
More about Ocrelizumab | More about Tysabri (natalizumab) | ||||||||
Ratings & Reviews | |||||||||
Ocrelizumab has an average rating of 4.9 out of 10 from a total of 176 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 49% reported a negative effect. |
Tysabri has an average rating of 7.8 out of 10 from a total of 98 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: ocrelizumab side effects in more detail. |
See also: Tysabri side effects in more detail. |
||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Tysabri prices |
||||||||
Dosage Form(s) Available | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Ocrevus | Other natalizumab brands include: Tyruko | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
624 hours |
360 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 406 drugs are known to interact with ocrelizumab:
|
A total of 405 drugs are known to interact with Tysabri:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
March 28, 2017 |
November 23, 2004 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.